Literature DB >> 33690677

Transgender-specific developmental milestones and associated experiences of violence, discrimination, and stigma among Filipinx transgender women who are sexually active with men.

Arjee J Restar1,2,3, Aaron S Breslow4,5, Harry Jin3, Ma Irene Quilantang1,2,6, Olivia Sison1,2,7, Amiel Nazer Bermudez1,2,8, Maylin Palatino1,2,6, Alexander Adia1,2, Susan Cu-Uvin1,2,9,10, Don Operario1,2, Jennifer Nazareno1,2.   

Abstract

BACKGROUND: For transgender people, reaching transgender (trans)-specific developmental milestones, including recognizing and expressing one's identity, plays an integral role in overall health, wellbeing, and the pursuit of gender affirmation. Yet trans people continue to face minority stressors, including structural violence (i.e., discrimination, violence, and stigma), which may interfere with the achievement of these milestones. Among trans women specifically, however, potential associations between gender developmental milestones and structural violence are not well characterized in the literature. In a sample of Filipinx (i.e., an inclusive term for describing non-binary genders in the Philippines) trans women who are sexually active with men (trans-WSM), we thus sought to: (a) describe the mean ages at which gender developmental milestones occur and (b) examine the associations between structural violence and mean ages at which at which Filipinx trans-WSM experience trans-specific developmental milestones.
METHODS: Using data from Project #ParaSaAtin, an online survey of Filipinx trans-WSM (n = 139), we mapped age-estimates per trans-specific milestones and then tested whether structural violence is associated with the mean age at which trans women experience trans-specific developmental milestones.
RESULTS: Overall, participants who reported higher levels of discrimination, stigma, and violence also experienced a later age for nearly each milestone (i.e., initial self-awareness of transfeminine identity, transfeminine expression in private, transfeminine expression in public, first consensual oral/vaginal/anal sex with a cisgender male partner, first consensual oral/vaginal/anal sex with a cisgender male partner as a trans women, and hormone integration) (all p-values <0.05). Of note, the single exception to this pattern was the non-significant association between stigma and initial disclosure of transfeminine identification to another person.
CONCLUSION: Results are consistent with psychological literature outlining a temporal sequence of developmental milestones among young trans-WSM. For young trans-WSM in the Philippines, data from this study demonstrate significant associations between structural violence and the achievement of developmental milestones. These findings highlight the need for trauma-informed, strengths-based programming and institutional policies that measure and mitigate anti-trans violence.

Entities:  

Mesh:

Year:  2021        PMID: 33690677      PMCID: PMC7942990          DOI: 10.1371/journal.pone.0248248

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  25 in total

1.  Protective Factors Among Transgender and Gender Variant Youth: A Systematic Review by Socioecological Level.

Authors:  Michelle Marie Johns; Oscar Beltran; Heather L Armstrong; Paula E Jayne; Lisa C Barrios
Journal:  J Prim Prev       Date:  2018-06

2.  "I Couldn't See a Downside": Decision-Making About Gender-Affirming Hormone Therapy.

Authors:  Thomas Daley; Daniel Grossoehme; Jenifer K McGuire; Sarah Corathers; Lee Ann Conard; Ellen A Lipstein
Journal:  J Adolesc Health       Date:  2019-06-10       Impact factor: 5.012

3.  Enhancing HIV/AIDS Surveillance in the Philippines to Ensure the Transgender Population's Visibility.

Authors:  Kalayaan C Bumanglag
Journal:  Am J Public Health       Date:  2018-01       Impact factor: 9.308

4.  Barriers and facilitators to uptake of condoms among Filipinx transgender women and cisgender men who have sex with men: A situated socio-ecological perspective.

Authors:  Arjee J Restar; Alexander Adia; Jennifer Nazareno; Laufred Hernandez; Theo Sandfort; Mark Lurie; Susan Cu-Uvin; Don Operario
Journal:  Glob Public Health       Date:  2019-10-20

5.  Primary care providers' willingness to continue gender-affirming hormone therapy for transgender patients.

Authors:  Deirdre A Shires; Daphna Stroumsa; Kim D Jaffee; Michael R Woodford
Journal:  Fam Pract       Date:  2018-09-18       Impact factor: 2.267

6.  Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus.

Authors:  Jae M Sevelius; Enzo Patouhas; Joanne G Keatley; Mallory O Johnson
Journal:  Ann Behav Med       Date:  2014-02

7.  Come Out, Get Out: Relations Among Sexual Minority Identification, Microaggressions, and Retention in Higher Education.

Authors:  Phoenix R Crane; Katarina S Swaringen; Matthew M Rivas-Koehl; Anthony M Foster; Tran H Le; Dana A Weiser; Amelia E Talley
Journal:  J Interpers Violence       Date:  2020-10-22

8.  Gender Affirmation: A Framework for Conceptualizing Risk Behavior among Transgender Women of Color.

Authors:  Jae M Sevelius
Journal:  Sex Roles       Date:  2013-06-01

9.  Hormone use among Nepali transgender women: a qualitative study.

Authors:  Pramod R Regmi; Edwin van Teijlingen; Sanjeev Raj Neupane; Sujan Babu Marahatta
Journal:  BMJ Open       Date:  2019-10-22       Impact factor: 2.692

10.  Factors Associated with Gender-Affirming Surgery and Age of Hormone Therapy Initiation Among Transgender Adults.

Authors:  Noor Beckwith; Sari L Reisner; Shayne Zaslow; Kenneth H Mayer; Alex S Keuroghlian
Journal:  Transgend Health       Date:  2017-10-01
View more
  1 in total

1.  A global cautionary tale: discrimination and violence against trans women worsen despite investments in public resources and improvements in health insurance access and utilization of health care.

Authors:  Sean Arayasirikul; Caitlin Turner; Dillon Trujillo; Sofia L Sicro; Susan Scheer; Willi McFarland; Erin C Wilson
Journal:  Int J Equity Health       Date:  2022-03-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.